UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $66
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $61 to $66.
UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $61 to $66.